HOLLAND & KNIGHT LLP

Lobbying for ALVOTECH SA · Biosimilar medicine development and manufacture

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · $20,000.00 income · posted Jan 18, 2026

Lobbying activity 1

Trade (domestic/foreign)

Trade policy and tariff impacts on the pharmaceutical industry.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem